Financials in USD. Standardized financial statements.
A compact view of how Strata Critical Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $197.14M | $248.69M | $225.18M | $146.12M | $50.53M | $23.43M | $31.20M |
| Revenue Growth? | -20.7% | +10.4% | +54.1% | +189.2% | +115.6% | -24.9% | 0.0% |
| Cost of Revenue? | $158.82M | $189.77M | $183.06M | $123.84M | $40.01M | $21.11M | $26.50M |
| Gross Profit? | $38.33M | $58.92M | $42.12M | $22.27M | $10.52M | $2.33M | $4.70M |
| Gross Margin? | +19.4% | +23.7% | +18.7% | +15.2% | +20.8% | +9.9% | +15.1% |
| Operating Expenses? | $48.13M | $92.84M | $110.24M | $75.80M | $34.61M | $12.69M | $16.24M |
| Operating Income? | -$9.81M | -$33.93M | -$68.12M | -$53.53M | -$24.09M | -$10.36M | -$11.54M |
| EBITDA? | -$2.91M | -$27.96M | -$61.01M | -$69.87M | -$23.50M | -$9.83M | -$11.07M |
| Income Before Tax | -$20.07M | -$27.56M | -$57.54M | -$28.03M | -$43.70M | -$10.16M | -$10.84M |
| Income Tax Expense | $0 | -$255,000 | -$1.47M | -$772,000 | -$3.64M | $0 | $0 |
| Net Income? | -$15.65M | -$27.31M | -$56.08M | -$27.26M | -$40.05M | -$10.16M | -$10.84M |
| EPS? | $-0.19 | $-0.35 | $-0.76 | $-0.38 | $-0.57 | $-0.81 | $-1.47 |
| Diluted EPS? | $-0.19 | $-0.35 | $-0.76 | $-0.38 | $-0.57 | $-0.81 | $-1.47 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality